Ditchcarbon
  • Customers
  1. Organizations
  2. Janssen Biotech, Inc.
Public Profile
Research Pending

This profile hasn't yet passed our validation checks

Submit your email to push it up the queue

We'll prioritize this organization's research and notify you when detailed sustainability data becomes available.

Pharmaceutical Preparation Manufacturing
US
updated 7 months ago

Janssen Biotech, Inc.

Company website

Janssen Biotech, Inc., a subsidiary of Johnson & Johnson, is a leading biopharmaceutical company headquartered in the United States. Founded in 2009, it has rapidly established itself in the biotechnology industry, focusing on innovative treatments in areas such as immunology, oncology, and infectious diseases. With a commitment to advancing healthcare, Janssen Biotech is renowned for its core products, including biologics and targeted therapies that address complex medical conditions. The company’s unique approach to drug development and its robust pipeline have positioned it as a key player in the global market. Notable achievements include the successful launch of groundbreaking therapies that have transformed patient care, solidifying Janssen Biotech's reputation for excellence and innovation in the biopharmaceutical landscape.

DitchCarbon Score

How does Janssen Biotech, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

78

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

29

Industry Benchmark

Janssen Biotech, Inc.'s score of 78 is higher than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.

88%

Let us know if this data was useful to you

Janssen Biotech, Inc.'s reported carbon emissions

Inherited from Johnson & Johnson

Janssen Biotech, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Johnson & Johnson, which influences its climate commitments and emissions reporting. As part of its corporate family, Janssen Biotech inherits climate initiatives and targets from Johnson & Johnson. This includes participation in the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all of which are aimed at reducing carbon emissions and promoting sustainability. However, specific reduction targets or achievements for Janssen Biotech are not detailed in the available data. While no absolute emissions figures are provided, the commitment to sustainability and climate action is evident through the initiatives cascaded from Johnson & Johnson. The company is aligned with industry standards for climate action, focusing on reducing its carbon footprint and contributing to broader environmental goals.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

1990200620072008200920102011201220132014201520162017201820192020202120222023
Scope 1
308,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
-
-
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
751,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
-
-
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
-
-
-
-
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
00,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Janssen Biotech, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Janssen Biotech, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Janssen Biotech, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Sandoz GmbH

AT
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Pathway International

AU
•
Pharmaceutical Preparation Manufacturing
Updated 21 days ago

Karyopharm Therapeutics Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Beigene

CN
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Guilford Pharmaceuticals Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

GALAPAGOS

US
•
Pharmaceutical Preparation Manufacturing
Updated 21 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250918.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy